Recently, loss-of-function (LoF) germline SH2B3 variants were reported by two independent groups in patients referred to their reference diagnostic laboratories for JMML who lacked a RAS pathway mutation [9, 10]. This evidence concerns the gene SH2B3 and juvenile myelomonocytic leukemia.